REQUEST A DEMO
Total
USD $0.00
Search more companies

Representaciones Farmaceuticas Galex S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Representaciones Farmaceuticas Galex S.A.S. Profile Updated: May 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Representaciones Farmaceuticas Galex S.A.S. is an enterprise located in Colombia, with the main office in Medellin. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on January 13, 2014. Representaciones Farmaceuticas Galex S.A.S. currently employs 8 (2024) people. There was a net sales revenue increase of 158.7% reported in Representaciones Farmaceuticas Galex S.A.S.’s latest financial highlights for 2023. During that time, Representaciones Farmaceuticas Galex S.A.S.’s total assets grew by 27.31%. The net profit margin of Representaciones Farmaceuticas Galex S.A.S. decreased by 3.39% in 2023.

Headquarters
Calle 33 42 B 06 Oficina 1006 y 1206
Medellin; Antioquia;

Contact Details: Purchase the Representaciones Farmaceuticas Galex S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Representaciones Farmaceuticas Galex S.A.S. report to view the information.
Outstanding Shares:
Purchase the Representaciones Farmaceuticas Galex S.A.S. report to view the information.
Incorporation Date:
January 13, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Representaciones Farmaceuticas Galex S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
158.7%
Total operating revenue
158.7%
Operating profit (EBIT)
-27.44%
Net Profit (Loss) for the Period
8.3%
Total assets
27.31%
Total equity
37.72%
Operating Profit Margin (ROS)
-6.26%
Net Profit Margin
-3.39%
Return on Equity (ROE)
-3.36%
Quick Ratio
-0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?